FMP

FMP

Enter

NVCR - NovoCure Limited

Profile of NovoCure Limited(NVCR), NovoCure Limited, an oncology company, engages in the development, manufacture, and commercializatio

About

ceo

Mr. Asaf Danziger

sector

Healthcare

industry

Medical - Instruments & Supplies

website

https://www.novocure.com

exchange

NASDAQ

Description

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

CIK

0001645113

ISIN

JE00BYSS4X48

CUSIP

G6674U108

Address

No. 4 The Forum

Phone

44 15 3475 6700

Country

JE

Employee

1,453

IPO Date

Oct 1, 2015

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep